SLNO FY 2020 Earnings — Soleno Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

SLNOSoleno Therapeutics, Inc.

$2B

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$2M

Operating Income

-$32M

Net Income

-$25M

EPS (Diluted)

$-3.68

Cash Flow

Operating Cash Flow

-$25M

Free Cash Flow

-$25M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$65M

Total Liabilities

$19M

Stockholders' Equity

$46M

Cash & Equivalents

$49M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$2M	-$2M	+4.5%
Operating Income	-$32M	-$23M	-37.7%
Net Income	-$25M	-$31M	+19.9%